Aimed Alliance Sends Letter on Nebraska’s PDAB Proposal
On May 7, 2024, Aimed Alliance submitted a letter to the Nebraska Banking, Commerce, and Insurance Committee regarding L.B.33, which…
Browsing: Drug Pricing: Policy Activity
Aimed Alliance Submits Comment in Support of CO PDAB Rare Disease Carveout
On April 4, 2024, Aimed Alliance submitted a letter of support to the Colorado General Assembly urging the Committee to…
Aimed Alliance Hosts Webinar on “Prescription Drug Affordability Boards 101: Everything You Need to Know”
On March 18, 2024, Aimed Alliance hosted a webinar on Prescription Drug Affordability Boards (PDABs) titled “PDAB 101: Everything You…
Aimed Alliance Comments on Oregon’s PDAB Process
On February 25, 2024, Aimed Alliance sent a letter to the Oregon Prescription Drug Affordability Board regarding its current patient…
Study Finds 340B Hospitals Significantly Markup Infusion Drugs
A recent study published in the New England Journal of Medicine examined the pricing practices of hospitals participating in the…
Senators Seek Input on Draft 340B Reform Bill
The Senate 340B Working Group is soliciting additional stakeholder input on key longstanding issues surrounding the Medicare 340B program. The…
Senate Pushes for FTC Progress in PBM Investigation
Senate Commerce Committee leaders, Maria Cantwell and Chuck Grassley, along with 12 lawmakers, are requesting an update from the Federal…
“Plan E”: A Proposal for a Universal Benefit for Cell and Gene Therapies
Cell and gene therapies (CGTs) have provided new optimism for patients living with diseases previously considered untreatable. These groundbreaking treatments…
Aimed Alliance Release New Resources on PDABs
On January 22, 2024, Aimed Alliance published two new resources on prescription drug affordability boards (PDABs). These boards, established at…
FDA Authorizes Florida’s Drug Importation Program
On January 5, 2024, the U.S. Food and Drug Administration (FDA) approved Florida’s Agency for Health Care Administration drug importation…